EMEA-002835-PIP01-20

Table of contents

Key facts

Active substance
  • fenofibrate
  • Pravastatin sodium
  • Ezetimibe
Therapeutic area
Cardiovascular diseases
Decision number
P/0405/2020
PIP number
EMEA-002835-PIP01-20
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Treatment of mixed hyperlipidaemia
Route(s) of administration
Oral use
Contact for public enquiries
Laboratoires SMB S.A.

E-mail: regulatory@smb.be
Tel: +32 24114828

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating